Insufficient scRNA-seq data for expression of EDA2R at single-cell level.
Insufficient scRNA-seq data for expression of EDA2R at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 850.24 | 652 / 653 | 97% | 15.16 | 588 / 605 |
adrenal gland | 99% | 998.68 | 256 / 258 | 89% | 10.07 | 204 / 230 |
prostate | 100% | 769.78 | 245 / 245 | 66% | 3.07 | 330 / 502 |
kidney | 70% | 187.08 | 62 / 89 | 94% | 15.02 | 851 / 901 |
skin | 86% | 998.04 | 1553 / 1809 | 77% | 11.30 | 363 / 472 |
breast | 93% | 466.15 | 426 / 459 | 69% | 4.17 | 770 / 1118 |
pancreas | 87% | 299.75 | 285 / 328 | 55% | 2.20 | 98 / 178 |
bladder | 100% | 449.33 | 21 / 21 | 31% | 1.83 | 154 / 504 |
ovary | 100% | 980.91 | 180 / 180 | 28% | 1.19 | 120 / 430 |
lung | 91% | 305.65 | 524 / 578 | 31% | 1.76 | 359 / 1155 |
uterus | 100% | 1102.54 | 170 / 170 | 21% | 1.47 | 97 / 459 |
intestine | 84% | 268.88 | 815 / 966 | 18% | 0.99 | 97 / 527 |
esophagus | 85% | 313.12 | 1229 / 1445 | 14% | 0.51 | 26 / 183 |
blood vessel | 99% | 800.88 | 1315 / 1335 | 0% | 0 | 0 / 0 |
brain | 29% | 59.92 | 770 / 2642 | 66% | 9.20 | 466 / 705 |
eye | 0% | 0 | 0 / 0 | 88% | 8.56 | 70 / 80 |
adipose | 83% | 344.01 | 1002 / 1204 | 0% | 0 | 0 / 0 |
spleen | 74% | 189.76 | 179 / 241 | 0% | 0 | 0 / 0 |
heart | 71% | 184.30 | 612 / 861 | 0% | 0 | 0 / 0 |
stomach | 42% | 101.23 | 150 / 359 | 22% | 1.44 | 64 / 286 |
muscle | 50% | 242.93 | 400 / 803 | 0% | 0 | 0 / 0 |
liver | 7% | 12.83 | 15 / 226 | 25% | 1.45 | 102 / 406 |
lymph node | 0% | 0 | 0 / 0 | 24% | 1.11 | 7 / 29 |
peripheral blood | 19% | 340.83 | 175 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.40 | 4 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0008544 | Biological process | epidermis development |
GO_0072332 | Biological process | intrinsic apoptotic signaling pathway by p53 class mediator |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0010668 | Biological process | ectodermal cell differentiation |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0005031 | Molecular function | tumor necrosis factor receptor activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | EDA2R |
Protein name | Tumor necrosis factor receptor superfamily member 27 (X-linked ectodysplasin-A2 receptor) (EDA-A2 receptor) |
Synonyms | XEDAR TNFRSF27 UNQ2448/PRO5727/PRO34080 |
Description | FUNCTION: Receptor for EDA isoform A2, but not for EDA isoform A1. Mediates the activation of the NF-kappa-B and JNK pathways. Activation seems to be mediated by binding to TRAF3 and TRAF6. . |
Accessions | ENST00000253392.5 [Q9HAV5-2] ENST00000374719.8 [Q9HAV5-1] ENST00000451436.6 [Q9HAV5-1] ENST00000396050.5 [Q9HAV5-2] Q9HAV5 |